SettleSignal
Settlements Data breachConsumer refundsPrivacy & biometricsEmployment How we verify Guides Help center For business Log in See what you may be owed →
Revance Therapeutics Settlement defendant
Evidence-verified Closed Aug 28, 2026 Proof needed Re-verifying source

Every dollar amount and date on this page is quoted from the official settlement document.

Revance Therapeutics Merger Securities Settlement

This settlement is closed. The claim deadline was August 28, 2026. It’s listed here for reference — the claim window has closed. Browse settlements open for claims →

If you bought Revance Therapeutics stock (RVNC) or its convertible notes between February 29, 2024 and February 6, 2025, you can file a claim for a share of a $17 million settlement. The deadline to file is August 28, 2026, and you must submit a claim form — nothing happens automatically.

Official eligibility wording

You may qualify if you purchased or acquired Revance Therapeutics common stock (ticker RVNC) or 1.75% fixed coupon convertible senior unsecured notes during February 29, 2024 through February 6, 2025 (close of Crown Laboratories merger). Checked against the official settlement source by SettleSignal on August 20, 2026.

Key facts

  • Who may qualify You may qualify if you purchased or acquired Revance Therapeutics common stock (ticker RVNC) or 1.75% fixed coupon Convertible Senior Unsecured Notes between February 29, 2024 and February 6, 2025 — the date Crown Laboratories completed its merger with Revance.
  • Estimated payout$17,000,000 total settlement fund; individual payout amounts cannot be determined at this time and depend on valid claims submitted and allocation formula
  • Claim deadlineAugust 28, 2026 (closed)
  • Proof requiredYes
  • What you needYou'll need to submit a Proof of Claim and Release Form with documentation of your Revance securities purchases and sales during the class period. Brokerage statements or trade confirmations showing your RVNC shares or convertible notes (CUSIP 761330AB5) will be required.
  • CourtUnited States District Court, Middle District of Tennessee (Case No. 3:25-cv-0018-EJR)

Important dates

Jul 13, 2026
passed
Exclusion deadline (passed)
Jul 13, 2026
passed
Objection deadline (passed)

How hard is this claim to file?

This settlement has an online claim form. File it before the deadline to get paid — the form asks for the details listed below. This claim form asks for 2 fields.

What the form asks

  • —
  • —

Watch out for

  • File before the deadline — late claims are rejected.
  • Use only the official claim form; avoid look-alike sites.

We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.

Verify it yourself

How we verified this record

How we verify records →

The key facts on this page were taken from the official settlement source, administered by AB Data, and last checked on August 20, 2026. We re-verify each field individually on a weekly pass.

2 official sources linked to this record.

Where to act

Claim link under recheck

SettleSignal suppresses claim links while verification is under recheck.

Status history

  1. Claim deadline passed.
  2. Settlement published after verification.
SettleSignal summary card for Revance Therapeutics Merger Securities Settlement — $17M fund, claim by August 28, 2026. Accepted official evidence on file.